Should You Buy Moderna (MRNA) Ahead of Earnings?
Moderna (MRNA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season....…
39,500€
9,36%
Echtzeit-Aktienkurs Moderna Inc.
Bid:
Ask:
Nachrichten zur Moderna Inc. Aktie
Moderna plans to open an enterprise solutions hub in the Philippines
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna, Inc.: Moderna Announces Establishment of an Enterprise Solutions Hub and Commercial Operations in The Philippines
The Enterprise Solutions Hub in the Philippines will support the Asia Pacific region and complements Modernas Enterprise Solutions Hubs in…
The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins
Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and Rollins are included in this Analyst Blog....…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.224.570$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-27...…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.269.140$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-26...…
Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?
Investors focus will likely be on Modernas (MRNA) pipeline, especially its late-stage pipeline candidates, when it reports first-quarter earnings....…
Better Healthcare AI Buy: Moderna vs. Medronic
Both of these companies are putting the focus on AI....…
Moderna (MRNA) Stock Sinks As Market Gains: What You Should Know
Moderna (MRNA) closed the most recent trading day at $130.07, moving -0.5% from the previous trading session....…
Second judge says US not liable in Moderna COVID-19 vaccine patent case
...By Blake Brittain
(Reuters) - Moderna Inc failed to persuade......…
$100 Invested In Moderna 5 Years Ago Would Be Worth This Much Today
read more...…
Better Buy: Pfizer vs. Moderna
Pfizer and Moderna each have lost more than 20% since the start of the year....…
Moderna: Covid bleibt ein wichtiger kurzfristiger Treiber - Aktienanalyse
New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Analyst Evan Wang von Guggenheim Securities:
Evan Wang, Analyst von Guggenheim Securities, leitet die Coverage…
Mehr als BioNTech, Moderna und Co
Der Weltgesundheitsmarkt wächst stetig. Innovative biotechnologische Ansätze und die fortschreitende Digitalisierung werden in den kommenden Jahren den Gesundheitsmarkt auf den…
Is Moderna Setting Expectations Too High?
The company may be overly optimistic when it comes to its outlook....…
How To Attend Moderna Q1 2023 Earnings Conference Call
read more...…
Can This AI Deal With IBM Be a Game-Changer for Moderna?
Moderna has already been using AI inside and outside of the lab....…
Moderna CEO Stephane Bancel sits down one-on-one with Jim Cramer
Stephane Bancel, CEO of Moderna, joins "Mad Money" host Jim Cramer to discuss the company's goals to expand vaccine production…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.719.539$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-20...…
Insiderhandel: Chief Executive Officer verkauft Aktien von Moderna im Wert von 5.715.262$
Bancel, Stephane - Vorstand - Tag der Transaktion: 2023-04-19...…
Moderna, Inc.: Moderna to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
CAMBRIDGE, MA / ACCESSWIRE / April 20, 2023 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics…
Moderna, IBM to use quantum computing, AI for mRNA research
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna teams up with IBM to put AI, quantum computing to work on mRNA technology used in vaccines
Modernas partnership with IBM comes as the drugmaker navigates its post-pandemic boom driven by its mRNA Covid vaccine. ...…
Moderna Partners With IBM Hoping AI Can Help Develop More mRNA Medicine
Modernas CEO said the partnership will allow the company to advance and accelerate its mRNA research and help it build…
Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development
Moderna Teams With IBM to Explore AI, Quantum Computing in Vaccine Development...…
Moderna, Inc.: Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
Moderna invests in developing quantum computing skills and exploring the use of quantum computing in developing future mRNA medicinesAgreement with…
Is Moderna About to Face the Same Challenge as Other Biotechs?
Investors have gotten used to Modernas rapid vaccine development....…
Moderna (MRNA) Gains As Market Dips: What You Should Know
In the latest trading session, Moderna (MRNA) closed at $142.82, marking a +0.13% move from the previous day....…
Moderna Stock: Bear vs. Bull
Moderna shares have delivered big for early investors....…
FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines
NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration said it has amended the emergency use authorizations or…
FDA Authorizes Changes To Simplify Use Of Moderna, Pfizer Bivalent COVID-19 Vaccines
The U.S. Food and Drug Administration said it has amended the emergency use authorizations or EUAs of COVID-19 bivalent mRNA…
Moderna Inc. stock outperforms competitors despite losses on the day
Moderna Inc. stock outperforms competitors despite losses on the day...…
Tuesday’s Top Analyst Upgrades and Downgrades: Boston Scientific, GM, JPMorgan, Match, Moderna, Snap, Uber, Wells Fargo and More
Tuesdays top analyst upgrades and downgrades included Agilon Health, Boston Scientific, General Motors, JPMorgan Chase, Match, Moderna, Okta, Palo Alto…
FDA withdraws authorization for older COVID vaccines by Moderna, Pfizer
...April 18 (Reuters) - The U.S. Food and Drug
Administration on Tuesday......…
Why did Moderna stock drop today? mRNA cancer therapy data
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Moderna Inc. stock underperforms Monday when compared to competitors
Moderna Inc. stock underperforms Monday when compared to competitors...…
Why Moderna Stock Plunged Today
Mildly positive results from a phase 2b cancer trial fell short of more hopeful investors expectations....…
BioNTech-Konkurrent Moderna: Aktie erneut deutlich unter Druck – Studiendaten im Fokus
Die Aktie des US-Biotechunternehmens Moderna steht zu Wochenbeginn erneut kräftig unter Druck. Rund eine Stunde vor dem US-Handelsende notiert das…
Stocks making the biggest moves midday: Alphabet, Charles Schwab, State Street, Moderna and more
These are the stocks posting the largest moves in midday trading....…
Blitz-Update: Dow & Co uneinheitlich, Boeing, Enphase Energy und Prometheus Biosciences stark, Alphabet, State Street und Moderna deutlich unter Druck
Die US-Aktienmärkte haben sich zum Auftakt der neuen Börsenwoche ohne klare Richtung präsentiert. Während sich die Standardwerte am Montag an…
Moderna shares fall despite promising data from cancer vaccine trial
Modernas mRNA vaccine, when combined with Mercks blockbuster drug Keytruda, showed promise in treating melanoma, a kind of skin cancer....…
Moderna Cancer-Therapy Sees More Upbeat Data
New data bolster the case for Moderna’s experimental cancer treatment, but the path to turning it into a marketable product…
Moderna, Roblox, State Street And Other Big Stocks Moving Lower On Monday
U.S. stocks traded mixed, with the Dow Jones dropping over 25 points on Monday. Here are some big stocks recording…
Biotechnologie: mRNA-Impfstoff senkt Hautkrebs-Rückfallrisiko deutlich
Die Daten zum Wirkstoff von Moderna stärken die Zuversicht für einen erfolgreichen Einsatz von mRNA-Technologie gegen Krebs. Doch die Forscher…
Moderna: Geben neue Daten der Aktie einen Schub?
Moderna (WKN: A2N9D9), das in Zusammenarbeit mit Merck an Krebsspritzen gegen Hauterkrankungen arbeitet, hat nun die Ergebnisse seiner zweiten klinischen…
This Prediction May Completely Change Your Opinion of Moderna
This stock may reward those who buy and hold for the long term....…
Prometheus, Merck, Moderna, Charles Schwab, and More Stock Market Movers
Merck agrees to buy Prometheus Biosciences for about $10.8 billion, and Charles Schwab reports quarterly earnings on Monday, kicking off…
Moderna, Inc.: Moderna and Merck Announce mRNA-4157, an Investigational Individualized Neoantigen Therapy, in Combination with KEYTRUDA , Demonstrated Superior Recurrence-Free Survival in Patients with High-Risk Stage III/IV Melanoma Following Comple
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in…
Die Verlierer des Tesla-Effekts und lukrative Nebenwerte-ETFs
In der heutigen Folge „Alles auf Aktien“ sprechen die Finanzjournalisten Daniel Eckert und Nando Sommerfeldt über die Image-Schlappe von Lilium,…
Moderna, Merck post detailed Phase 2 data for mRNA cancer shot in melanoma
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…